Impact of the COVID-19 Pandemic on Patients Affected By Chronic Diseases in Europe

2021-01-13T16:59:21+00:00 December 17th, 2020|Featured, Publications|

  • Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2020

  • Collaborator: Dermatology Center, GEM Resopso, University Sorbonne Paris Nord

  • Authors: Halioua B, Zetlaoui J, Astruc A, Lévy-Heidmann T, Testa D, Bombezin-Domino A, Radoszycki L

Patients with chronic medical conditions (CMC) require regular access to healthcare professionals and have to take long-term treatments. The coronavirus (COVID-19) may affect their clinical outcomes.